KLRS

Kalaris Therapeutics Inc

Investor Moves

NameValueActionChangePriceLast Price
Jim SimonsRenaissance Technologies
$382k66.2k shares
TrimQ1 2026
$359k
$5.77
$4.38
Jim SimonsRenaissance Technologies
$88.9K
AddQ4 2025
$89k
--
$4.38
Jim SimonsRenaissance Technologies
$393.4K
AddQ3 2025
$393k
--
$4.38
Jim SimonsRenaissance Technologies
$103.7K
AddQ2 2025
$104k
--
$4.38

Insider Trades

NameValueActionPriceLast Price
Akkaraju SrinivasDirector, 10 Percent Owner:
$1M244.3k shares
BuyMay 20, 2026
$4.83
$4.38
Hagen Brett RChief Accounting Officer
$13k1.9k shares
SellMar 20, 2026
$6.72
$4.38
Akkaraju SrinivasDirector, 10 Percent Owner:
$5M479.8k shares
BuyDec 18, 2025
$10.42
$4.38
Hagen Brett RChief Accounting Officer
$8.1k907 shares
SellMar 26, 2025
$8.97
$4.38

News

globenewswire.comKalaris to Present at Clinical Trials at the Summit 2026globenewswire.comJun 12globenewswire.comKalaris Reports First Quarter 2026 Financial Results and Provides Business Updatesglobenewswire.comMay 12